Publications by authors named "Virginio Filipazzi"

Claim this Profile
T
The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic.
Maria Silvia Cona, Eliana Rulli, Davide Dalu, Francesca Galli, Selene Rota, Virginio Filipazzi

Support Care Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients.
Sara Demurtas, Nicla La Verde, Selene Rota, Giovanni Casazza, Cristina Montrasio, Virginio Filipazzi

Pharmacogenomics J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study.
Andrea Luciani, Antonio Marra, Luca Toschi, Diego Cortinovis, Sergio Fava, Virginio Filipazzi

Clin Lung Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.
Alessandro Morabito, Maria Carmela Piccirillo, Paolo Maione, Andrea Luciani, Luigi Cavanna, Virginio Filipazzi

Lung Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study.
Beatrice De Troia, Davide Dalu, Virginio Filipazzi, Luigi Isabella, Nicoletta Tosca

Cancer Chemother Pharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.
Cesare Gridelli, Alessandro Morabito, Luigi Cavanna, Andrea Luciani, Paolo Maione, Virginio Filipazzi

J Clin Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study.
Sara Pilotto, Antonio Rossi, Tiziana Vavalà, Alessandro Follador, Marcello Tiseo, Virginio Filipazzi

Clin Lung Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.
Tiziana Vavalà, Alessandro Follador, Marcello Tiseo, Domenico Galetta, Alessandro Morabito, Virginio Filipazzi

Lung Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte colony-stimulating factors used in clinical practice: PoloNord Registry-Based Cohort Italian Study.
Daniele Fagnani, Luciano Isa, Magda Franca Verga, Paola Nova, Clelia Casartelli, Virginio Filipazzi

Tumori· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer.
Cesare Gridelli, Antonio Rossi, Massimo Di Maio, Silvana Leo, Virginio Filipazzi

Clin Lung Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial.
Cesare Gridelli, Ciro Gallo, Alessandro Morabito, Rosario Vincenzo Iaffaioli, Adolfo Favaretto, Virginio Filipazzi

J Thorac Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of bullous dermatitis induced by erlotinib.
Alessandro Oteri, Maria Teresa Cattaneo, Virginio Filipazzi, Sabrina Ferrario, Anna Gambaro

Oncologist· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study.
Daniele Fagnani, Alessandro Bertolini, Laura Catena, Maurizio Tomirotti, Marilena Visini, Virginio Filipazzi

Blood Coagul Fibrinolysis· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.
Cesare Gridelli, Paolo Maione, Alfonso Illiano, Franco Vito Piantedosi, Adolfo Favaretto, Virginio Filipazzi

J Clin Oncol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type.
Annarita Conconi, Giovanni Martinelli, Catherine Thiéblemont, Andrés J M Ferreri, Liliana Devizzi, Virginio Filipazzi

Blood· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supportive care in patients with advanced non-small-cell lung cancer.
M Di Maio, F Perrone, C Gallo, R V Iaffaioli, L Manzione, Virginio Filipazzi

Br J Cancer· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis